Houston, Texas

Houston, Texas 77077

0 studies enrolling now · 9 studies all time

What they study most

Alopecia Areata, Corneal Epithelial Wound, Neurotrophic Keratopathy, Parkinson Disease, Schizophrenia

Studies at this site

• A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA) — Running, not enrolling
• Open-label Trial in Parkinson's Disease (PD) — Completed
• Flexible-Dose Trial in Early Parkinson's Disease (PD) — Completed
• A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia — Completed
• A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia — Completed
• Fixed-Dose Trial in Early Parkinson's Disease (PD) — Completed
• Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3) — Completed
• Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy — Completed
• Safety and Effectiveness of OBG vs.a Bandage Contact Lens for Large Corneal Epithelial Defects in Patients Post-PRK. — Completed